BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 23910226)

  • 1. Haemoglobin, neutrophil to lymphocyte ratio and platelet count improve prognosis prediction of the TNM staging system in nasopharyngeal carcinoma: development and validation in 3,237 patients from a single institution.
    Chang H; Gao J; Xu BQ; Guo SP; Lu RB; Li G; Huang SM; Han F; Liu ZG; Tao YL; Tu ZW; Chen C; Li XH; Xia YF
    Clin Oncol (R Coll Radiol); 2013 Nov; 25(11):639-46. PubMed ID: 23910226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic values of hematological biomarkers in nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy.
    Ye L; Oei RW; Kong F; Xu T; Shen C; Wang X; He X; Kong L; Hu C; Ying H
    Eur Arch Otorhinolaryngol; 2018 May; 275(5):1309-1317. PubMed ID: 29589142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic value of the ratio of neutrophils to lymphocytes before and after intensity modulated radiotherapy for patients with nasopharyngeal carcinoma.
    Liu J; Wei C; Tang H; Liu Y; Liu W; Lin C
    Medicine (Baltimore); 2020 Jan; 99(2):e18545. PubMed ID: 31914029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Nomogram for Patients with Nasopharyngeal Carcinoma after Intensity-Modulated Radiotherapy.
    Wu S; Xia B; Han F; Xie R; Song T; Lu L; Yu W; Deng X; He Q; Zhao C; Xie C
    PLoS One; 2015; 10(8):e0134491. PubMed ID: 26248338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic nomogram for patients with Nasopharyngeal Carcinoma incorporating hematological biomarkers and clinical characteristics.
    Li J; Chen S; Peng S; Liu Y; Xing S; He X; Chen H
    Int J Biol Sci; 2018; 14(5):549-556. PubMed ID: 29805306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of immune inflammation-based index for predicting the clinical outcome in patients with nasopharyngeal carcinoma.
    Zeng X; Liu G; Pan Y; Li Y
    J Cell Mol Med; 2020 Aug; 24(15):8326-8349. PubMed ID: 32603520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretreatment platelet count improves the prognostic performance of the TNM staging system and aids in planning therapeutic regimens for nasopharyngeal carcinoma: a single-institutional study of 2,626 patients.
    Chen YP; Zhao BC; Chen C; Shen LJ; Gao J; Mai ZY; Chen MK; Chen G; Yan F; Liu S; Xia YF
    Chin J Cancer; 2015 Mar; 34(3):137-46. PubMed ID: 25962816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Glasgow Prognostic Score predicts poor survival in cisplatin-based treated patients with metastatic nasopharyngeal carcinoma.
    Chen C; Sun P; Dai QS; Weng HW; Li HP; Ye S
    PLoS One; 2014; 9(11):e112581. PubMed ID: 25393117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Significance of Neutrophil to Lymphocyte Ratio, Lymphocyte to Monocyte Ratio, and Platelet to Lymphocyte Ratio in Patients with Nasopharyngeal Carcinoma.
    Lu A; Li H; Zheng Y; Tang M; Li J; Wu H; Zhong W; Gao J; Ou N; Cai Y
    Biomed Res Int; 2017; 2017():3047802. PubMed ID: 28321405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma Epstein-Barr viral DNA complements TNM classification of nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy.
    Zhang L; Tang LQ; Chen QY; Liu H; Guo SS; Liu LT; Guo L; Mo HY; Zhao C; Guo X; Cao KJ; Qian CN; Zeng MS; Shao JY; Sun Y; Ma J; Hong MH; Mai HQ
    Oncotarget; 2016 Feb; 7(5):6221-30. PubMed ID: 26716900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Inflammation-Based Stage (I Stage) Predicts Overall Survival of Patients with Nasopharyngeal Carcinoma.
    Li JP; Chen SL; Liu XM; He X; Xing S; Liu YJ; Lin YH; Liu WL
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27854304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic nomogram for refining the prognostication of the proposed 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy.
    Pan JJ; Ng WT; Zong JF; Lee SW; Choi HC; Chan LL; Lin SJ; Guo QJ; Sze HC; Chen YB; Xiao YP; Kan WK; O'Sullivan B; Xu W; Le QT; Glastonbury CM; Colevas AD; Weber RS; Lydiatt W; Shah JP; Lee AW
    Cancer; 2016 Nov; 122(21):3307-3315. PubMed ID: 27434142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of post-radiotherapy neutrophil-to-lymphocyte ratio in locally advanced nasopharyngeal carcinoma.
    Ou D; Wang X; Wu M; Xue F; Li Y; Hu C; He X
    Strahlenther Onkol; 2020 Mar; 196(3):252-261. PubMed ID: 31701168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic score models for survival of nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy and chemotherapy.
    Zeng L; Guo P; Li JG; Han F; Li Q; Lu Y; Deng XW; Zhang QY; Lu TX
    Oncotarget; 2015 Nov; 6(36):39373-83. PubMed ID: 26415223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutoff point of neutrophil-to-lymphocyte ratio for predicting survival in nasopharyngeal carcinoma.
    Setakornnukul J; Chanvimalueng W; Patumanond J; Thephamongkhol K
    Medicine (Baltimore); 2021 Aug; 100(34):e27095. PubMed ID: 34449514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of detailed MR imaging report of primary tumor and lymph nodes on prognostic nomograms for nasopharyngeal carcinoma after intensity-modulated radiotherapy.
    Wan Y; Tian L; Zhang G; Xin H; Li H; Dong A; Liang Y; Jing B; Zhou J; Cui C; Chen M; Sun Y; Xie C; Liu L; Shao Y
    Radiother Oncol; 2019 Feb; 131():35-44. PubMed ID: 30773185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An inflammatory biomarker-based nomogram to predict prognosis of patients with nasopharyngeal carcinoma: an analysis of a prospective study.
    Li XH; Chang H; Xu BQ; Tao YL; Gao J; Chen C; Qu C; Zhou S; Liu SR; Wang XH; Zhang WW; Yang X; Zhou SL; Xia YF
    Cancer Med; 2017 Jan; 6(1):310-319. PubMed ID: 27860387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the seventh and eighth editions of the UICC/AJCC staging system for nasopharyngeal carcinoma: analysis of 1317 patients treated with intensity-modulated radiotherapy at two centers.
    Yang XL; Wang Y; Liang SB; He SS; Chen DM; Chen HY; Lu LX; Chen Y
    BMC Cancer; 2018 May; 18(1):606. PubMed ID: 29843648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy of a Staging System for Prognosis of 5-Year Survival of Patients With Nasopharyngeal Carcinoma Who Underwent Chemoradiotherapy.
    Huang CI; Chen LF; Chang SL; Wu HC; Ting WC; Yang CC
    JAMA Otolaryngol Head Neck Surg; 2017 Nov; 143(11):1086-1091. PubMed ID: 28975193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors and prediction-score model for distant metastasis in nasopharyngeal carcinoma treated with intensity-modulated radiotherapy.
    Li AC; Xiao WW; Wang L; Shen GZ; Xu AA; Cao YQ; Huang SM; Lin CG; Han F; Deng XW; Zhao C
    Tumour Biol; 2015 Nov; 36(11):8349-57. PubMed ID: 26014515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.